[Ip-health] AP: Health experts slam US deal for large supply of virus drug

Baker, Brook b.baker at northeastern.edu
Thu Jul 2 08:20:57 PDT 2020


It's really pretty stunning that academics like Dr. Penny Ward can not only defend high prices but also nationalistic stockpiling of medicines that leaves 95+% of the global population waiting in line for months for one of the first medicines that can treat severe COVID-19 illness.  The US gobbled up 60% of Gilead's initial donations of remdesivir (900,000 of 1,500,000 doses) and now it is gobbling up 93% of the next three months' supply.  Just because countries can and have done things doesn't make it morally or ethically "reasonable."

 
    Dr. Penny Ward of King’s College London, noted that many countries have
    legal provisions that allow them to prohibit the exportation of drugs to
    other countries during an emergency.
    
    “It is unreasonable to expect that the U.S. government should deny their
    population access to drugs manufactured in the USA,” she said.
    
    Ward pointed out that another drug that may help people with severe
    COVID-19, the cheap steroid dexamathasone, is long off-patent and available
    globally.

Brook

Professor Brook K. Baker
Northeastern U. School of Law
416 Huntington Ave.
Boston, MA 02115
Honorary Research Fellow, University of KwaZulu Natal
Health GAP (Global Access Project) Senior Policy Analyst
(w) 617-373-3217
(c) 617-259-0760
b.baker at northeastern.edu
Skype:  brook_baker
 

    
    




More information about the Ip-health mailing list